Effectiveness Of Adalimumab In Combination With Intense Pulsed Light And Radiofrequency Therapy (Laight (R)) For Severe Hidradenitis Suppurativa: A Case Report

Hidradenitis suppurativa (HS also named as acne inversa) is a chronic skin disease characterized by relapsing formation of abscesses, inflammatory nodules, and fistulas. In moderate-to-severe disease, HS leads to the formation of scarring and thus irreversible tissue destruction. In the past few years, two new treatment options became available: adalimumab, the first biologic therapy approved for HS (Humira (R), AbbVie), and a noninvasive, device-based treatment utilizing a combination of intense pulsed light and radiofrequency (LAight (R) therapy, LENICURA, Germany). Here, we report a case of a Hurley stage III patient where the positive effect of adalimumab could be enhanced by simultaneously applying LAight (R) therapy. Moreover, long-term symptom control could be achieved under monotherapy with LAight (R) after adalimumab was terminated.